Literature DB >> 7860060

Trisomy 7 in non-neoplastic tubular epithelial cells of the kidney.

S Knuutila1, M L Larramendy, P Elfving, W el-Rifai, A Miettinen, F Mitelman.   

Abstract

The cellular origin of trisomy 7 in non-neoplastic kidney tissue specimens from 10 patients, seven with malignant tumors and three with non-neoplastic kidney diseases, was studied by the MAC (morphology antibody chromosomes) technique, which allows analysis of cellular morphology/histology, immunophenotype, and chromosomal aneuploidy by conventional cytogenetics, and/or fluorescent in situ hybridization in both interphase and mitotic cells. In primary cultures, trisomy 7 was detected primarily in cytokeratin-positive cells. Among freshly isolated renal cells, the trisomy was mainly observed in proximal tubular cells positive to brush-border antigen, and, to a lesser extent, in distal tubular cells positive to Tamm-Horsfall glycoprotein. The frequency of trisomy 7 in lymphocytes expressing CD3 or CD22 antigens isolated from non-neoplastic and tumor tissues was substantially lower than in the epithelial cells and was not increased compared with that in control lymphocytes from peripheral blood. The results thus demonstrate that the non-neoplastic kidney cells with trisomy 7 are mainly normal epithelial cells, preferentially those of the proximal tubule.

Entities:  

Mesh:

Year:  1995        PMID: 7860060     DOI: 10.1007/bf00209393

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  33 in total

1.  Clonal chromosome aberrations in cell cultures of synovial tissue from patients with rheumatoid arthritis.

Authors:  A Ermis; T Hopf; R Hanselmann; K Remberger; C Welter; S Dooley; K D Zang; W Henn
Journal:  Genes Chromosomes Cancer       Date:  1993-04       Impact factor: 5.006

2.  Atherosclerotic plaque as a benign tumor?

Authors:  R Vanni; L Cossu; S Licheri
Journal:  Cancer Genet Cytogenet       Date:  1990-07-15

3.  Trisomy 7, trisomy 10, and loss of the Y chromosome in short-term cultures of normal kidney tissue.

Authors:  P Elfving; J C Cigudosa; R Lundgren; J Limon; N Mandahl; U Kristoffersson; S Heim; F Mitelman
Journal:  Cytogenet Cell Genet       Date:  1990

4.  Clonal chromosome aberrations in normal kidney tissue from patients with renal cell carcinoma.

Authors:  G Kovacs; P Brusa
Journal:  Cancer Genet Cytogenet       Date:  1989-02

5.  Chromosome abnormalities in Peyronie's disease.

Authors:  K D Somers; B A Winters; D M Dawson; M S Leffell; G L Wright; C J Devine; D A Gilbert; C E Horton
Journal:  J Urol       Date:  1987-04       Impact factor: 7.450

6.  Trisomy 7 and sex chromosome loss in human brain tissue.

Authors:  S Heim; N Mandahl; Y Jin; S Strömblad; E Lindström; L G Salford; F Mitelman
Journal:  Cytogenet Cell Genet       Date:  1989

7.  Involvement of chromosomes 7 and 12 in large bowel cancer: trisomy 7 and 12q-.

Authors:  R Becher; Z Gibas; A A Sandberg
Journal:  Cancer Genet Cytogenet       Date:  1983-08

8.  Cytogenetics of 12 cases of renal adenocarcinoma.

Authors:  B de Jong; J W Oosterhuis; V J Idenburg; S M Castedo; A Dam; H J Mensink
Journal:  Cancer Genet Cytogenet       Date:  1988-01

9.  Cytogenetic study of four cancers of the prostate.

Authors:  V R Babu; B J Miles; J C Cerny; L Weiss; D L Van Dyke
Journal:  Cancer Genet Cytogenet       Date:  1990-08-01

10.  Chromosomal abnormalities and their correlations with asbestos exposure and survival in patients with mesothelioma.

Authors:  M Tiainen; L Tammilehto; J Rautonen; T Tuomi; K Mattson; S Knuutila
Journal:  Br J Cancer       Date:  1989-10       Impact factor: 7.640

View more
  2 in total

Review 1.  Review of allelic loss and gain in prostate cancer.

Authors:  G S Bova; W B Isaacs
Journal:  World J Urol       Date:  1996       Impact factor: 4.226

2.  End-stage kidney disease: gains of chromosomes 7 and 17 and loss of Y chromosome in non-neoplastic tissue.

Authors:  Ondrej Hes; Radek Síma; Jana Nemcová; Milan Hora; Stela Bulimbasic; Dmitry V Kazakov; Tomás Urge; Tomás Reischig; Miroslav Dvorák; Michal Michal
Journal:  Virchows Arch       Date:  2008-09-16       Impact factor: 4.064

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.